Gene Therapy Manufacturing Workshop

Sponsored by Brammer Bio and MaxCyte

GENE THERAPY MANUFACTURING WORKSHOP
Strategies for BioManufacturing Viral-based Gene Therapy Vectors – Early-Stage Development Through Clinical Production

Welcome Remarks / Introduction:
Robert Preti, Ph.D., Chairman, Alliance for Regenerative Medicine (ARM); President, PCT, A Caladrius Company; SVP, Manufacturing and Technical Operations, Caladrius Biosciences

Chair:
Jessica Carmen, Ph.D., Director of Business Development, Cellular Therapy Partnerships, MaxCyte

Speakers:
James Brown, Ph.D., VP, Corporate Development, Aldevron
Matthew Caple, VP, Site Operations, Brammer Bio
Mike Kelly, Director, Asset Leadership and Portfolio Management, Gene Therapy, Biogen
Michael Roberts, Ph.D., Chief Scientific Officer, Synpromics